Skip to main content

Table 6 Comparison of methods used for quantitative mesenchymal stem/stromal cells (MSC) detection (Adapted from ref. [300])

From: Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications

Technique

Detection

Advantages

Disadvantages

PCR/histology

Transplanted-cell specific DNA sequences or antigens

High sensitivity

No need to label the cells

Need animal sacrifice, biopsy,

Postmortem samples from patients

Optical imaging

Fluorescent dyes/proteins

High throughput

Good for longitudinal studies

Small animals only,

Low resolution,

Non-stable

Flow cytometry

Fluorescent dyes/proteins

High specificity,

Quantification of live cells

Preclinical use only

MRI

Contrast agents

Clinically useful

High spatial resolution

Whole-body scanning

Quantification is difficult

Cytotoxicity of certain labeling agents

Radionuclear

Radioisotope labels

Quantification feasible using SPECT

Whole-body scanning

High sensitivity

Limited spatial resolution

Ionizing radiation

FND

Fluorescence

Large animal models (pigs)

PK/PD of transplanted cells

Biodistribution of transplanted cells

Background-free imaging

Single-cell detection sensitivity

High throughput quantification

No interference with cell potency

Need animal sacrifice

  1. PCR polymerase chain reaction, PET positron emission tomography, SPECT single-photon emission computed tomography, FND fluorescent nanodiamond, PK pharmacokinetic, PD pharmacodynamics